• Language
Customer Survey
Tell us about your project
Contact us to discuss how we can help you achieve your research goals

Technology: Platform

Lab Platform

Novogene has genomic sequencing labs in the US at The University of California at Davis campus, China, Singapore and the UK (Cambridge), with a total area of nearly 20,000 ㎡, including a 2,000 ㎡ GMP facility and a 2,000 ㎡ clinical laboratory.

The UC Davis location was opened in early 2016 and utilizes the NovaSeq 6000, HiSeq X Ten, and HiSeq 4000 sequencing platforms to serve customers in North and South America.

Next generation sequencing services and analysis of human, plant, and animal samples for research purposes.

Novogene has successfully established a CAP-accredited medical lab in Tianjin, China. This world class facility enables us to provide high-quality clinical sequencing services globally. The Tianjin lab is able to test liquid biopsy samples using Novogene’s digital PCR platform. In partnership with AITbiotech, Novogene has also launched a genomics center in Singapore to deliver NGS services in Asia Pacific, Middle East and Africa (AMEA) region.

Sequencing Platform

Computing Platform

Our supercomputing capability allows us to analyze 280,000 whole human genomes per month. This capability aligns with our unsurpassed NGS capacity, enabling us to run many projects of different sizes and still deliver the data to our customers in a timely fashion. Our state-of-the-art platform is comprised of DELL computing nodes with total memory of 410 TB, computing power of up to 1,727 T flops, and Isilon storage capacity of 62 PB. Our storage capacity can expand as our needs grow, ensuring our customers’ data is backed up and available as needed.